GREENLIGHT BIOSCIENCES

What this means for you

Not registered yet, but its 23 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98236427

Mark type

Stylized text

Filed

23 Oct 2023

Attorney of record

Rachelle A. Dubow, Esq.

Goods and services

• Class 001 — Chemicals: Chemical reagents and RNA sequences being chemical reagents for agricultural purposes, and not medical or veterinary purposes, namely, for crop protection and to improve plant health and plant yield; chemical treatments applied to seeds, plants and crops to improve plant health and yield
• Class 005 — Pharmaceuticals: Chemical reagents and RNA sequences being chemical reagents used to repel or destroy insects, pests, parasites, and vermin; Agricultural products, namely, insecticides, pesticides, fungicides; preparations for destroying vermin; Chemical reagents and RNA sequences being chemical reagents used for improving bee health; Pharmaceutical products and veterinary products for human and animal health in the nature of vaccines and RNA therapeutics for the treatment of parasitic infection or infestations, infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer; Antibiotics; Vaccines; Gene therapy products, namely, mRNA therapeutics and siRNA therapeutics for medical or clinical use for the treatment of infectious diseases, respiratory diseases, immune system diseases, cardiovascular diseases, and cancer; RNA in the nature of vaccines and therapeutics for scientific, research, medical, pharmaceutical, veterinary, agricultural, industrial and manufacturing use for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, parasitic infection or infestation, and cancer
• Class 042 — Scientific and technological services: Research and development services in the field of RNA for scientific, engineering, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use; research and development services in the field of synthetic and recombinant biology and formulations; design and engineering in the field of producing RNA and cell-free processing; research and development services in the field of producing, manufacturing, and processing of RNA and RNA formulations for scientific, research, medical, pharmaceutical, veterinary, agricultural food, chemical and energy production, industrial and manufacturing use; research and development services in the field of formulations for the delivery of RNA for scientific, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use

Owner

• GreenLight Biosciences, Inc., Durham, NC, US

Prosecution history

• 02 Mar 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 02 Mar 2026 — LETTER OF SUSPENSION E-MAILED
• 02 Mar 2026 — SUSPENSION LETTER WRITTEN
• 18 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 18 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 18 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 17 Nov 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 17 Nov 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 18 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 18 Aug 2025 — NON-FINAL ACTION E-MAILED
• 18 Aug 2025 — NON-FINAL ACTION WRITTEN
• 27 May 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 26 Nov 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 26 Nov 2024 — LETTER OF SUSPENSION E-MAILED
• 26 Nov 2024 — SUSPENSION LETTER WRITTEN